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Background: Personal factors (PFs) are internal factors that determine functioning and the individuals’ experience
of disability. Their coverage by patient-reported outcome measures (PROMs) has not been examined in rheumatoid
arthritis (RA) so far. The aims of this study were to identify PFs important in the life stories of people with RA and to
determine their coverage by PROMs used in RA.
Methods: The qualitative data of people with RA was explored to identify PFs. Additionally a systematic literature
search was conducted to find PROMs used in RA. PROMs items were linked to the components, domains and
categories of the International Classification of Functioning, Disability and Health (ICF) to determine the coverage of
important PFs by PROMs.
Results: Twelve PFs were found to be important in the life stories of people with RA. The PFs coping and reflecting
about one’s life in an optimistic way were covered most frequently, each by 14 of the 42 explored PROMs, while job
satisfaction was not covered at all. The London Coping with Rheumatoid Arthritis Questionnaire, General Self-Efficacy
Scale, Arthritis Self-Efficacy Scale, Rheumatoid Arthritis Self-Efficacy Questionnaire and Revised Ways of Coping Inventory
covered most PFs. Nineteen PROMs did not cover any of the PFs.
Conclusion: Several PFs were identified as important in the life stories of people with RA, but only 55% of the
PROMS covered some of these PFs. When evaluating PFs important to people with RA, health professionals should
be alert on which PROMs can be used to assess which PFs.
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Rheumatoid arthritis (RA) is a chronic autoimmune dis-
ease, characterized by joint inflammation, pain, joint swell-
ing, morning stiffness, and fatigue which may lead to loss
of functioning in daily life [1]. The prevalence ranges from
0,5-2% and is 3 - 4 times higher in women than in men
[2]. However, the current understanding of the burden of
the disease comprises not only clinical symptoms, but also
other aspects that have an impact on living with RA, in-
cluding environmental factors and personal factors, such
as people’s social support or self-efficacy [3-5].
The International Classification of Functioning, Dis-
ability and Health (ICF) [6] is a common conceptual
framework used to understand, describe and measure
the dimensions of human functioning, disability and
health [7]. Within the ICF, an individual’s functioning is
conceptualized as result of the interplay between body
functions and structures, activities and participation and
contextual factors that include environmental and per-
sonal factors (PFs) [6].
PFs have played a tangential part in relation to ICF-
based health outcome research. In the ICF, PFs are de-
fined as internal factors that determine functioning and
the individuals’ experience of disability. PFs comprise
“features of the individual” such as coping, social back-
ground and psychological factors impacting health out-
comes [6]. However, even if a few researchers have
explored PFs through consensus processes [8], system-
atic reviews [9] or qualitative interviews with patients
[10], they are not yet classified according to the ICF
“taxonomy” [6,7].
For example, the RA ICF core set was developed to
provide a set of categories that best describes the prob-
lems of functioning of people with RA [11]. Within three
validation studies based on qualitative data several PFs
were identified as meaningful which have not been cov-
ered by the ICF core sets [12-15]. Further, even though
single PFs have been explored in people with RA [16,17],
they have been left out in the examination of the cover-
age of the perspectives of patients with RA by patient-
reported outcome measures (PROMs), as it has been
done in other chronic diseases [18-20]. Thus, it is un-
clear how PROMs cover PFs important to people with
RA. Additionally, PFs and their meaning to people with
RA may change over time and the course of disease
[21,22]. Hence, they need to be explored within a long-
term perspective over the life course.
Furthermore, the new and effective biologic therapies
facilitate the inclusion of other important aspects such
as PFs as targets of non-pharmacological treatment of
people with RA [6,23,24]. For example, interventions tar-
geting PFs, such as coping strategies or medication be-
liefs, could support individuals to achieve their fullest
potential on functioning, to reduce the impact of RA[24,25], and to increase medication adherence [26]. To
assess the need for or to evaluate non-pharmacological
treatment in clinical practice or rehabilitation targeting
PFs, health professionals and researchers should be alert
on which PROMs cover which PFs.
The aims of this study were to identify PFs important
in the life stories of people with RA and to determine
their coverage by PROMs used in RA.
Methods
We used a mixed methods design consisting of a quali-
tative analysis, a systematic literature search and a link-
ing process. The current project was part of a larger
study [27,28].
Exploration of qualitative data to identify personal factors
important in the life stories of people with RA
Firstly, a secondary analysis of qualitative data of a previ-
ous study [29,30] was conducted. In the respective study,
patients from the rheumatologic outpatient clinic of the
Medical University of Vienna, Austria, diagnosed with
RA [31] were asked for participation. A small sample
size of 15 participants with a diverse range was aimed to
gather rich and meaningful data [32]. Recruitment used
a maximum variation sampling strategy [33] in terms of
sex, age, former professional status and disease duration.
Inclusion criteria were “being early retired” at the time
of the interviews, having past employment experience
(≥20 hours per week), no history of psychiatric and/or
other neuro-motor disease and German as first language.
Since we were interested in the identification of PFs
which could be complex, such as coping or resilience,
we decided to use people’s life stories and to follow the
biographical narrative interpretative method (BNIM)
[33,34]. In accordance to the study aim the interviews’
verbatim transcripts of the life stories were used to deter-
mine PFs which were important over the life and disease
course of people with RA. Therefore, each transcript was
analyzed by two researchers independently (MD, MS, and
TAS). In case of disagreement, each case was discussed in
a research panel of three people who together made a final
informed decision, whether or not a certain PF was
encompassed in the respective life story. PFs which were
found among different life stories were identified based on
the exploration of people’s interpretation of their life’s ex-
perience and their biography [34] and used for the explor-
ation of their coverage by PROMs. A flow chart of the
different steps of the BNIM is depicted in Figure 1. For de-
tailed information we refer to further literature [33,34].
Systematic literature search to find PROMs used in RA
Secondly, we conducted a systematic literature search in
2013 using PubMed, CINAHL and PsycInfo to find
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Figure 1 Flow diagram of the data collection and analysis following the BNIM. (Initials) = researcher(s) who conducted the respective step
of the BNIM.
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the articles: [(rheumatoid arthritis)] AND [(outcome)
OR (assessment) OR (instrument) OR (measure) OR
(questionnaire)] AND [(self-reported) OR (patient-re-
ported) OR (patient perspective)]. For inclusion, articles
had to be written in English and published in a peer-
reviewed journal and the description of the use or devel-
opment of at least one PROM had to be contained in the
title or the abstract. Candidate articles were independently
reviewed by two researchers (MD and AB) using a data
extraction form, to identify the descriptions of PROMs. A
PROM was included when the following criteria were ap-
plied: assessing functioning and/or functional health and/
or those PFs which were identified in the qualitative ana-
lyses. PROMs items which were not provided within thesearticles were obtained from reference checking or on re-
quest from their authors. PROMs specifically designed for
children or adolescents and single-VAS-assessments for
disease activity of RA were excluded.
Linking process to determine the coverage of important
personal factors by PROMs
Finally, we determined which PFs were covered by
which PROMs using the ICF [6] as reference. Items of
the PROMs were linked to ICF categories by two re-
searchers (MD and MC). In case of disagreement an
informed decision was made by one further researcher
skilled and experienced in the ICF linking process
(TAS). The linking process followed a standard pro-
cedure by the use of the current ICF-linking rules [35].
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the ICF-linking rule referring to items encompassing
different constructs, an example is shown in Figure 2.
Articles providing ICF categories linked to the selected
PROMs were used.
The linked ICF categories of each PROM were com-
pared to the PFs from the qualitative data by mapping
them to each other. Finally, PROMs were explored in
order to report how many PROMs were available to as-
sess each PF and those PFs for which no PROM existed.
An example is given in Figure 2.
Ethical considerations
Participants received information about study procedures
and ethical considerations and gave written and oral in-
formed consents. Confidentiality was guaranteed and
names were changed in the given examples. The study was









Figure 2 Example: Linking process to determine the coverage of imp
Comparison of one personal factor to one linked item of the Rheumatoid Self
Functioning, Disability and Health, PROMs = Patient-reported outcome measuResults
Personal factors important in the life stories of people
with RA
For the current study, we used the data of 15 people
with RA, 11 women and 4 men with a median age of
54 years and disease duration of 11 years [29,30]. Demo-
graphic data is depicted in Table 1.
In the secondary analysis of the life stories of people
with RA the following 12 PFs were identified as being
important: Adaptation to changed living conditions;
coping; eating habits and weight concerns; involvement
into disease management; job satisfaction; meaningful
activities for the individual and/or the societal context;
own attitudes; reflecting about one’s life in an optimistic
way; resilience; self-efficacy; sense of coherence and social
appreciation.
In the following section, we give two examples of import-
ant PFs: In the life story of Hans, a 58 years old varnisher,
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efficacy)
d750 Informal social 
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e3 Support and 
relationship
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I believe I could educate my 
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arthritis to help with the 
strains that arthritis can 
make on relationships.
ortant personal factors by patient-reported outcome measures.
-efficacy Questionnaire; Abbreviations: ICF = International Classification of
res, RASE = Rheumatoid Self-efficacy Questionnaire.
Table 1 Demographic data of the participants
Women Men
n (%) Total 11 (73) 4 (27)
n (%) International Standard Classification
of Education (ISCED) level 3: completed
vocational education or secondary education
premising the access to higher education
6 (55) 3 (75)
Median Age (interquartile range) 52 (43–61) 56 (42–58)
Median Disease duration (interquartile range) 10 (8–20) 14 (10–26)
Table 2 Frequency of personal factors per sex
R Personal factors n (%) f (%) m (%)
1 Own attitudes 13 (87) 11 (100) 2 (50)
2 Adaptation to changed living conditions 11 (73) 9 (82) 2 (50)
3 Meaningful activities for the
individual and/or the social context
12 (80) 8 (73) 4 (100)
4 Eating habits and weight concerns 10 (67) 8 (73) 2 (50)
5 Coping 9 (60) 5 (45) 4 (100)
6 Reflecting about one’s life in
an optimistic way
7 (47) 7 (64) 0
6 Involvement into disease management 7 (47) 7 (64) 0
6 Self-efficacy 7 (47) 6 (55) 1 (25)
7 Sense of Coherence 6 (40) 4 (36) 2 (50)
8 Job satisfaction 5 (33) 5 (45) 0
9 Social appreciation 4 (27) 3 (27) 1 (25)
9 Resilience 4 (27) 2 (18) 2 (50)
Abbr.: R = Rank, n = number, f = female, m =male.
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his life story contained several descriptions on changes
which were adaptations to living with RA:
“Depressing when you suddenly become useless at the
age of 40, not knowing how life will go on and how to
get oneself and one’s family. So, my wife worked half
time and I took care of the children, as far as that was
possible”. (First interview, lines 51–53)
Another example is Maria, a 42 years old woman. She
did not let the disease “rule” her life and supported
others to care about their health and wellbeing. Finally,
Maria became an “advocate” for people with RA. We
identified self-efficacy and involvement into disease man-
agement when she told about her engagement in acquir-
ing knowledge and skills.
“What I wanted to know was how to handle it [the
disease]? So, I asked my physician [rheumatologist] to
prepare me for the case that the worst happens and we
talked it through. I have written down everything. In the
case I found myself in troubles, I looked through my notes
and could help myself”. (First interview, lines 537–546)“My ambition spurred me on, not to accept everything
related to the disease and to let it rule my life. I have
bought medical books, attended specialist conferences
[on rheumatic diseases], I went to libraries and studied
[RA specific] drugs and their side effects. I started to
understand the physician a little when he talked about
the medication. I felt that I could have a determining
influence on the decision which drug should be tried
next”. (First interview, lines 687–701) “I realized that
meanwhile I was engaged in the management of my
disease to the same extent as I was engaged in my job
formerly”. (First interview, lines 719–721)
Three PFs were found to be important in the life stor-
ies of women only. These were reflecting about one’s life
in an optimistic way, involvement into disease manage-
ment and job satisfaction. While coping and meaningful
activities for the individual and/or the social context wasimportant in the life story of all men, the same was true
for own attitudes in women. The frequency and percent-
age of identified PFs per sex are depicted in Table 2.
PROMs used in RA
The systematic literature search resulted in 1280 hits, of
which 831 were excluded due to 107 duplicates and 724
irrelevant articles. Finally, 449 articles were used to iden-
tify the PROMs used in RA, as described in Figure 3.
In total forty-two PROMs met our inclusion criteria.
They are listed and described in Table 3.
PROMs coverage of important personal factors
The ICF categories linked to the items of eight PROMs
[36,45,51,59,64,68,70,76] were used from existing litera-
ture [28,77,78]. The mapping of PFs to the PROMs is
depicted in Table 4.
The PFs coping and reflecting about life in an optimistic
way were covered most frequently (each by 14 PROMs),
followed by resilience and self-efficacy (each by 12
PROMs). Compared to that, job satisfaction was not cov-
ered by any of the PROMs. The PF own attitudes was cov-
ered by six, involvement into disease management by five,
sense of coherence by four and meaningful activities by two
PROMs. Adaptation to changed living conditions, social
appreciation and eating habits and weight concerns were
covered once, each by the London Coping with Rheuma-
toid Arthritis Questionnaire (LCRAQ) [79].
The LCRAQ covered most (nine) PFs, followed by the
General Self-Efficacy Scale (GSES) [48,49] which covered
six PFs. The Arthritis Self-Efficacy Scale (ASES) [38], the
Rheumatoid Arthritis Self-Efficacy Questionnaire (RASE)
[67] and the Revised Ways of Coping Inventory (WOC-R)
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Figure 3 Flow diagram.
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the Health Assessment Questionnaire (HAQ) except the
14 Activities of Daily Living Multidimensional HAQ (14
ADLMDHAQ) [51-53,61,75], as shown in Table 4.
Discussion
In the current study we identified 12 PFs being import-
ant in the life stories of people with RA and explored their
coverage by 42 PROMs used in RA. The results of this
study can support health professionals and researchers in
their selection of which PROMs to use, when assessing the
need for or evaluating the effect of non-pharmacological
treatment in clinical practice or rehabilitation [80] target-
ing the identified PFs.
PFs which were found to be important to people with RA
could get more emphasis in ICF-based health outcome
research. For example, self-efficacy was found to facilitate
the maintenance of physical activity [4] and to decrease
fatigue [81], pain [82] and the development of cardiovascu-
lar risk [83,84]. Since cardiovascular diseases account forapproximately 50% of mortality [85], the prevention of
cardiovascular risk is an important target in the disease
management of RA [86] including pharmacological and
non-pharmacological methods [87]. Thus, health outcome
research focusing on PFs with strong evidence for their
health determining effect could be of great value to support
individuals achieving their fullest functioning and health.
Due to unequal proportion of female and male partici-
pants, the identified gender differences of PFs need to be
treated with caution. The findings could indicate a differ-
ence in the meaning of these PFs in the life stories be-
tween women and men with RA. Therefore, the selection
of the outcomes and related PROMs should take into ac-
count potential gender differences to consider the prefer-
ences and values regarding PFs of women and men in the
evaluation of health care interventions.
Even though, most of the explored PROMs were not de-
signed to assess a range of PFs, one PROM was outstanding
in its coverage of PFs: the LCRAQ which could be used to
address most of the identified PFs. The GSES could be
Table 3 Characteristics of the identified patient-reported outcome measures
Abbreviations Names of patient-reported outcome measures Items
AIMS2-SF Arthritis Impact Measurement Scales Short Form [36] 26
APaQ Activity Participation Questionnaire [37] 2
ASES Arthritis Self-Efficacy Scale [38] 20
B-WOC-R Brief Revised Ways of coping inventory [39] 18
BRAF MDQ Bristol Arthritis Fatigue Multi-Dimensional Questionnaire [40] 20
BRAF NRS Bristol Arthritis Fatigue Numerical Rating Scale [40] 3
CFS Chalder Fatigue Scale [41] 11
CIS 20R Checklist Individual Strength [42] 20
CIS 8R Checklist Individual Strength [42] 8
C-RAQ Coping with Rheumatoid Arthritis Questionnaire [25] 20
DRP Disease Repercussion Profile [43] 6
EC-17 Effective Musculoskeletal Consumer Scale (Short Form) [44] 17
EQ-5D EuroQuoL Health questionnaire [45] 5
FACIT-F Functional Assessment Chronic Illness Therapy (Fatigue) [46] 13
FSS Fatigue Severity Scale [47] 9
GSES General Self-Efficacy Scale [48,49] 10
HADS Hospital Anxiety and Depression Scale [50] 14
HAQ Health Assessment Questionnaire [51] 20
HAQ-II Health assessment questionnaire ii [52] 10
HAQ-DI Health Assessment Questionnaire Disability Index [53] 20
JP SES Joint Protection Self-efficacy Scale [54] 10
LCRAQ London Coping with Rheumatoid Arthritis Questionnaire [55] 36
LOT-R Life Orientation Test-Revised [56] 8
MAF Multi-dimensional Assessment of Fatigue [57] 15
MFI Multi-dimensional Fatigue Inventory [58] 20
MHAQ Modified Health Assessment Questionnaire [59] 8
MHLC - C Multidimensional Health Locus of Control C-Form [60] 18
PI-HAQ Personal Impact Health Assessment Questionnaire [61] 20
PRO-CLARA Patient Reported Outcome - Clinical Arthritis Activity [62] 21
RAID Rheumatoid Arthritis Impact of Disease score [63] 12
RAPID 3 Routine Assessment of Patient Index Data [64] 24
RAQoL Rheumatoid Arthritis Quality of life [65] 30
ROAD Recent-Onset Arthritis Disability Index [66] 12
RASE Rheumatoid Arthritis Self-Efficacy Questionnaire [67] 28
SACRAH Score for Assessment & Quantification of Chronic Rheumatoid Affections of the Hands [68] 23
SF-36 Short-Form Health Survey 36-item [69,70] 36
SOC-13 Sense of Coherence scale-13 [71] 13
SSQS & SQT Social Support Questionnaire Transactions & Satisfaction with supportive transactions [72] 46
SSS MOS Social Support Survey [73] 20
WOC-R Revised Ways of Coping Inventory [74] 50
10 ADLMDHAQ 10 Activities of Daily Living Multidimensional Health Assessment Questionnaire [75] 10
14 ADLMDHAQ 14 Activities of Daily Living Multidimensional Health Assessment Questionnaire [75] 14
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Table 4 Coverage of personal factors by patient-reported outcome measures
Important personal factors
PROMs Adaptation to changed
living conditions
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Table 4 Coverage of personal factors by patient-reported outcome measures (Continued)
Important personal factors
PROMs Job satisfaction Meaningful activities for the
individual/the social context
Own attitudes Reflecting about one’s life
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Table 4 Coverage of personal factors by patient-reported outcome measures (Continued)
Important personal factors











































PROMs = abbreviated names of patient-reported outcome measures; + = personal factor is covered by the specific patient-reported outcome measures.
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RASE and the WOC-R were found to assess five different
PFs, respectively. While the PFs coping, reflecting about
one’s life in an optimistic way and sense of coherence could
be assessed by all of these PROMs, adaptation to changed
living conditions, eating habits and weight concerns, and so-
cial appreciation was found to be covered by the LCRAQ
only. In addition, the PROMs which covered most of the
PFs, could be used to measure the PFs own attitudes (ex-
cept the WOC-R) and resilience (except the ASES). Conse-
quently, one of these PROMs could be selected for the
evaluation of health care interventions having regard to the
different PFs important in the life stories of people with
RA. However, for the use in clinical practice and research,
other psychometric properties and applicability in different
cultural contexts need to be considered.
Commonly used PROMs in clinically routine, e.g. the
HAQ could be combined with others. Only the 14
ADLMDHAQ [75] covers PFs (n = 2), while the other ver-
sions of the HAQ do not cover any of the PFs. In addition,
it would be interesting to develop RA specific PROMs that
address adaptation to changed living conditions, social ap-
preciation, eating habits and weight concerns, job satisfac-
tion and meaningful activities, since these PFs have rarely
been addressed in the PROMs. In the clinical routine and
rehabilitation, health professionals such as nurses, occupa-
tional therapists or physiotherapists, may use other assess-
ments and thus, could address PFs to complement and/or
to conduce to success of pharmacological treatment for
people with RA [26].
This research had some limitations. An inclusion of
PROMs published in various languages could give valuable
information about their potential utilization to assess PFs.
Another study could include PFs important to patients of
younger age to determine their coverage of PROMs, based
on previous research [88]. In addition, further studies could
focus on the perspectives of patients of different cultural
backgrounds or specific person groups such as parents or
patients with recent onset. The so called member checking
method could have contributed to the credibility of the
findings. In the current project we explored the content val-
idity of PROMs, referring to their coverage of concepts
which are relevant to the target population [89]. Despite de-
termining PROMs’ content validity, a critical appraisal of
other measurement properties could have provided add-
itional important information. However, we did not explore
other psychometric properties of the selected PROMs since
this was not the focus of our study. Additional studies are
warranted to generalize the findings of the current project
to other people with RA.
Conclusion
Taken together, the identified PFs are important in the
life stories of people with RA and could be addressed inclinical practice and rehabilitation by different health
professionals in order to support their patients’ function-
ing and health. The LCRAQ, the GSES, the ASES, the
RASE and the WOC-R could be used when assessing
the need for or evaluating health care interventions tar-
geting the identified PFs and thus contribute to an in-
creasing benefit for people with RA. Furthermore the
findings can be used for further development of existing
PROMs and to guide their use in clinical practice, re-
habilitation and research.
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